Edition:
International

John Miller

German lab, J&J still hashing out details of COVID-19 vaccine clot collaboration

Jun 18 2021

ZURICH A scientist investigating rare blood clots possibly linked to AstraZeneca's and Johnson & Johnson's COVID-19 vaccines has yet to start a planned collaboration with the U.S. company, he said, as talks over their research pact continue.

Former Swiss "Magic Mountain" TB clinics treat COVID to stay relevant

Jun 17 2021

WALD/DAVOS, Switzerland (Reuters) -Swiss mountain sanatoriums whose fresh-air and sunlight cures once drew tuberculosis patients from across Europe are reinventing themselves for a new generation: Patients suffering from the lingering effects of COVID-19.

Former Swiss "Magic Mountain" TB clinics treat COVID to stay relevant

Jun 17 2021

* Approach contrasts with U.S., UK long COVID outpatient therapy

Europe secures 55,000 doses of Roche-Regeneron COVID drug hope

Jun 03 2021

BRUSSELS The European Union has secured about 55,000 doses of a potential treatment for COVID-19 based on a cocktail of monoclonal antibodies developed by U.S. drugmaker Regeneron and Swiss pharmaceutical giant Roche, an EU spokesman said.

Novartis' nuclear therapy helps men with prostate cancer live longer - data

Jun 03 2021

ZURICH Men with a deadly form of advanced prostate cancer who failed other treatments survived four months longer after getting an experimental, tumour-targeting radiation therapy from Swiss drugmaker Novartis, data released on Thursday showed.

Summit secures additional $2.4 billion for COVID shots for poor countries

Jun 02 2021

GENEVA/ZURICH (Reuters) -Countries and private donors pledged nearly $2.4 billion on Wednesday to the COVAX vaccine-sharing plan, expanding efforts to make COVID-19 shots more available to people in poorer nations.

Moderna plans mix of COVID-19 vaccine doses with new Lonza deal

Jun 02 2021

ZURICH (Reuters) -Moderna is gearing up to halve the dose of its COVID-19 vaccine, the U.S. drugmaker said on Wednesday, so that it can also be used to combat variants and inoculate children.

Explainer-How worried should we be about blood clots linked to AstraZeneca, J&J vaccines?

May 27 2021

ZURICH (Reuters) -International drug regulators have said the benefits of using COVID-19 vaccines developed by Johnson & Johnson and AstraZeneca outweigh risks as they investigate reports of extremely rare, but potentially fatal blood clots.

World News